Parker Institute for Cancer Immunotherapy Welcomes Karen Knudsen as Chief Executive Officer
Parker Institute for Cancer Immunotherapy posted on X:
“Join us in welcoming Karen Knudsen as PICI’s Chief Executive Officer! A visionary in oncology, healthcare delivery and nonprofit strategy, Dr. Knudsen embodies the values that define PICI: scientific rigor, bold thinking and a commitment to transformative patient impact.
As CEO of American Cancer Society and ASC CAN, Dr. Knudsen expanded research, advocacy and patient support initiatives.
At Jefferson Healthcare and Sidney Kimmel Comprehensive Cancer Center, she grew a multi-state oncology network and advanced research expanding early access to cutting-edge cancer care.
From advancing precision oncology to building coalitions for progress, Dr. Karen Knudsen unites scientific excellence and strategic leadership to drive patient impact. We’re proud to welcome her to PICI.”
ASCO shared this post on X, adding:
“Congratulations Karen Knudsen on your appointment as CEO of Parker Institute for Cancer Immunotherapy!
We look forward to continued collaboration with you and the oncology community to advance cancer research and ensure the highest quality patient care for all.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023